Preferred Name | Levonordefrin | |
Synonyms |
LEVONORDEFRIN 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-,(R-(R*,S*))- Levonordefrin Neo-Cobefrin (-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl Alcohol |
|
Definitions |
The levoisomer of nordefrin, a synthetic catecholamine and norepinephrine derivative with sympathomimetic and antihypertensive effects. Levonordefrin's antihypertensive effect is exerted through activation of alpha 2-adrenergic receptors in the cardiovascular control center of the CNS thereby suppressing the sympathetic output from the brain and subsequently lowering blood pressure. Levonordefrin binds to and activates peripheral alpha 2- adrenergic receptors, thereby causing vasoconstriction. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47584 |
|
CAS_Registry |
18829-78-2 829-74-3 |
|
Chemical_Formula |
C9H13NO3 |
|
code |
C47584 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
The levoisomer of nordefrin, a synthetic catecholamine and norepinephrine derivative with sympathomimetic and antihypertensive effects. Levonordefrin's antihypertensive effect is exerted through activation of alpha 2-adrenergic receptors in the cardiovascular control center of the CNS thereby suppressing the sympathetic output from the brain and subsequently lowering blood pressure. Levonordefrin binds to and activates peripheral alpha 2- adrenergic receptors, thereby causing vasoconstriction. |
|
FDA_UNII_Code |
V008L6478D |
|
FULL_SYN |
LEVONORDEFRIN 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-,(R-(R*,S*))- Levonordefrin Neo-Cobefrin (-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl Alcohol |
|
Has_Salt_Form | ||
label |
Levonordefrin |
|
Legacy Concept Name |
Levonordefrin |
|
Preferred_Name |
Levonordefrin |
|
prefixIRI |
Thesaurus:C47584 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0520472 |
|
subClassOf |